Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
World Health Organization.
Cancer pain relief.
World Health Organization, (1990),
[2.]
H. McQuay, D. Carroll, A.R. Jadad, P. Wiffen, A. Moore.
Anticonvulsant drugs for management of pain: a systematic review.
BMJ, 311 (1995), pp. 1047-1052
[3.]
P. Wiffen, S. Collins, H.J. McQuay, D. Carroll, A. Jadad, R.A. Moore.
Anticonvulsant drugs for acute and chronic pain. En: Biblioteca Cochrane Plus, n.° 2.
Update Software, (2005),
[4.]
P. Wiffen, H.J. McQuay, R.A. Moore.
Carbamazepine for acute and chronic pain. En: Biblioteca Cochrane Plus, n.° 2.
Update Software, (2005),
[5.]
P. Wiffen, H.J. McQuay, J.E. Edwards, R.A. Moore.
Gabapentin for acute and chronic pain. En: Biblioteca Cochrane Plus, n.° 2.
Update Software, (2005),
[6.]
S. Harkins, J. Linford, J. Cohen, T. Kramer, L. Cueva.
Administration of Clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study.
J Craniomandib Disord, 5 (1991), pp. 179-186
[7.]
L.J. Crofford, M.C. Rowbotham, P.J. Mease, I.J. Russell, R.H. Dworkin, A.E. Corbin, et al.
Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo controlled trial.
Arthritis Rheum, 52 (2005), pp. 1264-1273
[8.]
I.M. Richards, S.M. Fraser, J.A. Hunter, H.A. Capell.
Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis.
Ann Rheum Dis, 46 (1987), pp. 667-669
[9.]
U.R. Rao, M.U. Naidu, T.R. Kumar, U. Shobha, M.A. Askar, N. Ahmed, et al.
Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis–a double blind study.
J Rheumatol, 22 (1995), pp. 1235-1240
[10.]
G.J. McCleane.
Does gabapentin have an analgesic effect on background,movement and referred pain? A randomised, double-blind, placebo controlled study.
Pain Clin, 13 (2001), pp. 103-107
[11.]
G. Magni.
The use of antidepressants in the treatment of chronic pain. A review of the current evidence.
Drugs, 42 (1991), pp. 730-748
[12.]
H.J. McQuay, B.A. Nye, M. Tramer, D. Carroll, P.J. Wiffen, R.A. Moore.
A systematic review of antidepressants in neuropathic pain.
Pain, 68 (1996), pp. 217-227
[13.]
M.B. Max, S.A. Lynch, J. Muir, S.E. Shoaf, B. Smoller, R. Dubner.
Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.
N Engl J Med, 326 (1992), pp. 1250-1256
[14.]
L.M. Arnold, E.V. Hess, J.I. Hudson, J.A. Welge, S.E. Berno, P.E. Keck Jr.
A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia.
Am J Med, 112 (2002), pp. 191-197
[15.]
D. Goldenberg, M. Mayskiy, C. Mossey, R. Ruthazer, C. Schmid.
A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia.
Arthritis Rheum, 39 (1996), pp. 1852-1859
[16.]
A. Gur, M. Karakoc, K. Nas, R. Cevik, J. Sarac, S. Ataoglu.
Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
Rheumatol Int, 22 (2002), pp. 188-193
[17.]
P. Hannonen, K. Malminiemi, U. Yli-Kerttula, R. Isomeri, P. Roponen.
A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.
Br J Rheumatol, 37 (1998), pp. 1279-1286
[18.]
O. Vitton, M. Gendreau, J. Gendreau, J. Kranzler, S.G. Rao.
A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia.
Hum Psychopharmacol, 19 (2004), pp. S27-S35
[19.]
L.M. Arnold, Y. Lu, L.J. Crofford, M. Wohlreich, M.J. Detke, S. Iyengar, et al.
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arthritis Rheum, 50 (2004), pp. 2974-2984
[20.]
U.M. Anderberg, MIKL.
Citalopram in patients with fibromyalgia-a randomized, double-blind, placebo-controlled study.
Eur J Pain, 4 (2000), pp. 27-35
[21.]
J. Norregaard, H. Volkmann, B. Danneskiold-Samsoe.
A randomized controlled trial of citalopram in the treatment of fibromyalgia.
Pain, 61 (1995), pp. 445-449
[22.]
E.A. Fors, H. Sexton, K.G. Gotestam.
The effect of guided imagery and amitriptyline on daily fibromyalgia pain: a prospective, randomized, controlled trial.
J Psychiatr Res, 36 (2002), pp. 179-187
[23.]
P. O’Malley.
Treatment of fibromyalgia with antidepressants. A metaanalysis.
J Gen Intern Med, 15 (2000), pp. 659-666
[24.]
J.H. Atkinson, M.A. Slater, R.A. Williams.
A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain.
Pain, 76 (1998), pp. 287-296
[25.]
J.H. Atkinson, M.A. Slater, D.R. Wahlgren.
Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity.
Pain, 83 (1999), pp. 137-145
[26.]
C. Dickens, M. Jayson, C. Sutton, F. Creed.
The relationship between pain and depression in a trial using paroxetine in sufferers of chronic low back pain.
Psychosomatics, 41 (2000), pp. 490-499
[27.]
S.M. Salerno, J.J. Bra.
The effect of antidepressant treatment on chronic back pain.
Arch Intern Med, 162 (2002), pp. 19-24
[28.]
S. Schreiber.
A randomized trial of fluoxetine versus amitryptiline in musculo-skeletal pain.
Isr J Psychiatric Relat Sci, 38 (2001), pp. 88-94
[29.]
P.U. Rani, M.U. Naidu, V.B. Prasad, T.R. Rao, J.C. Shobha.
An evaluation of antidepressants in rheumatic pain conditions.
Anesth Analg, 83 (1996), pp. 371-375
[30.]
D. Fishbain.
Evidence-based data on pain relief with antidepressants.
Ann Med, 32 (2000), pp. 305-316
[31.]
P. Onghena, B. Van Houdenhove.
Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies.
Pain, 49 (1992), pp. 205-219
[32.]
G. Ash, C.M. Dickens, F.H. Creed, M.I. Jayson, B. Tomenson.
The effects of dothiepin on subjects with rheumatoid arthritis and depression.
Rheumatology (Oxford), 38 (1999), pp. 959-967
[33.]
W.H. Koh, I. Pande, A. Samuels, S.D. Jones, A. Calin.
Low dose amitriptyline in ankylosing spondylitis: a short term, double blind, placebo controlled study.
J Rheumatol, 24 (1997), pp. 2158-2161
[34.]
C.C. Engel Jr, E.A. Walker, A.L. Engel, J. Bullis, A. Armstrong.
A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain.
J Psychosom Res, 44 (1998), pp. 203-207
Esta revisión ha sido presentada en el Simposio de Dolor en Reumatología de la Sociedad Española de Reumatología (SER) (Guadalajara, 22 de octubre de 2005).
Para desarrollar este estudio, se realizaron 2 revisiones sistemáticas con una beca SER. La revisión sistemática de los anticonvulsivos en el dolor reumático fue realizada por Claudia A. Pereda Testa y Jackeline Uson Jaeger. La revisión sistemática de los antidepresivos en el dolor reumático fue realizada por Isabel Sánchez Magro y Marta Neira Álvarez. Ambas revisiones sistemáticas fueron dirigidas y coordinadas por Loreto Carmona.
Copyright © 2006. Elsevier España S.L. Barcelona
Contenido especial sobre COVID-19
- Neumomediastino espontáneo: una manifestación extramuscular de la dermatomiositis anti-MDA5. Reporte de 2 casos
- The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam
- Análisis de factores implicados en el desarrollo de respuesta humoral a la vacunación frente a SARS-CoV-2 en pacientes con enfermedad reumática en tratamiento biológico
- The “autoimmune/inflammatory syndrome induced by adjuvants” (ASIA) after COVID-19 infection: A case report
Herramientas
Publique en
Reumatología Clínica
Artículos de acceso gratuito
Reumatol Clin. 2022;18:331-7
Reumatol Clin. 2022;18:231-5
Reumatol Clin. 2020;16:437-46